The pharmaceutical industry operates in conditions of constant change and instability. The rapid advancement of technology, new scientific insights, and constant external pressures that have intensified in recent years – from regulatory requirements, inflation, raw material shortages to increasing geopolitical tensions.
For us at JGL, adapting to these processes is not a reactive response but is integrated into our way of thinking and doing business. Agility and quick adaptation to new circumstances have been our forte in recent years, allowing us to maintain double-digit growth even in conditions where challenges changed from month to month.
This means that we do not wait for the resolution of individual crises but proactively strengthen resilience, secure alternative supply sources, expand production capacities, and enter new technologies… We are focused on sustainable business, so it is no coincidence that we are the first Croatian issuer of SLB bonds in the private non-financial sector, recognized and supported by financial markets. At the same time, we continue to invest in research and development, analyze new therapeutic solutions, and raise internal quality standards. The values on which JGL stands – responsibility, respect, community, and sustainability – are precisely what enables us to grow in an uncertain environment.
I am confident that, regardless of any new demands, rules, and challenges, we will continue to strengthen our position and achieve our ambitiously set goals. We have just come out of a super election year in which nearly four billion people around the world went to the polls. The election results in certain countries had a significant, direct impact on business, but also shaped the broader social and economic context in which we operate.
